Kazuto Furuyama

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Diagnostic utility of high-mobility group box 1 for acute exacerbations of idiopathic pulmonary fibrosis.

Diagnostic utility of high-mobility group box 1 for acute exacerbations of idiopathic pulmonary fibrosis.

Journal: Scientific reports

Published: July 19, 2025

Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for TTF-1 negative advanced nonsquamous non-small cell lung cancer: A multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102).

Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for TTF-1 negative advanced nonsquamous non-small cell lung cancer: A multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102).

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 06, 2025

Prognostic impact of muscle mass in idiopathic interstitial pneumonia: analysis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias.

Prognostic impact of muscle mass in idiopathic interstitial pneumonia: analysis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias.

Journal: BMC pulmonary medicine

Published: May 21, 2025

Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for advanced nonsquamous non-small cell lung cancer with impaired renal function: A multicenter, single-arm phase 2 trial (RESTART, LOGiK 2002).

Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for advanced nonsquamous non-small cell lung cancer with impaired renal function: A multicenter, single-arm phase 2 trial (RESTART, LOGiK 2002).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 31, 2025

Cicatricial organising pneumonia associated with fibrosing interstitial pneumonia - a clinicopathological study.

Cicatricial organising pneumonia associated with fibrosing interstitial pneumonia - a clinicopathological study.

Journal: Histopathology

Published: September 28, 2020

Hypermethylation of the CpG dinucleotide in epidermal growth factor receptor codon 790: implications for a mutational hotspot leading to the T790M mutation in non-small-cell lung cancer.

Hypermethylation of the CpG dinucleotide in epidermal growth factor receptor codon 790: implications for a mutational hotspot leading to the T790M mutation in non-small-cell lung cancer.

Journal: Cancer genetics

Published: October 07, 2014

Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression.

Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression.

Journal: Cancer chemotherapy and pharmacology

Published: April 07, 2014

Sensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR-tyrosine kinase inhibitors.

Sensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR-tyrosine kinase inhibitors.

Journal: Cancer science

Published: December 09, 2012

Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer.

Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 02, 2012

A case of pulmonary tuberculosis complicated with severe thrombocytopenia during treatment

A case of pulmonary tuberculosis complicated with severe thrombocytopenia during treatment

Journal: Kekkaku : [Tuberculosis]

Published: June 19, 2012

Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer.

Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 04, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026